Table 7 Relation between patient characteristics and steroid receptor status by immunocytochemistry and dextran-coated charcoal [159]
From: Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
| Â | Â | Estrogen receptor positive | Progesterone receptor positive | ||
|---|---|---|---|---|---|
Parameter | n (%) | ICC (%) | DCC (%) | ICC (%) | DCC (%) |
Axillary node status (n = 241) | Â | Â | Â | Â | Â |
   N0 | 120 (49.8) | 88 (73.3) | 98 (81.7) | 83 (69.1) | 93 (77.5) |
   N+ | 121 (50.2) | 75 (62.0) | 89 (73.6) | 75 (61.9) | 94 (77.7) |
Tumor size (cm) (n = 229a) | Â | Â | Â | Â | Â |
   <2 | 86 (37.6) | 59 (68.6) | 69 (80.2) | 60 (69.8) | 69 (80.2) |
   2-5 | 128 (55.9) | 88 (68.8) | 101 (78.9) | 84 (65.6) | 100 (78.1) |
   >5 | 15 (6.6) | 8 (53.3) | 9 (60.0) | 8 (53.3) | 9 (60.0) |
Tumor histology (n = 241) | Â | Â | Â | Â | Â |
   Invasive ductal | 171 (71.0) | 120 (70.2) | 136 (79.5) | 119 (69.6) | 136 (79.5) |
   Lobular | 38 (15.8) | 26 (68.4) | 31 (81.6) | 22 (57.9) | 30 (78.9) |
   Otherb | 32 (13.2) | 17 (53.1) | 20 (62.5) | 17 (53.1) | 21 (65.6) |
Tumor grade (n = 217)c | Â | Â | Â | Â | Â |
   1 + 2 | 142 (65.4) | 106 (74.7) | 118 (83.1) | 104 (73.2) | 119 (83.8) |
   3 | 75 (34.6) | 41 (54.7) | 52 (69.3) | 36 (48.0) | 53 (70.7) |
Patient age (y) (n = 241) | Â | Â | Â | Â | Â |
   ≤50 | 63 (26.1) | 26 (41.3) | 42 (66.7) | 45 (71.4) | 54 (85.7) |
   >50 | 178 (73.9) | 137 (77.0) | 145 (81.5) | 113 (63.5) | 133 (74.7) |